Gene polymorphisms of methylenetetrahydrofolate reductase in patients with venous thromboembolism

HAN Xuan-mao,LIU Xiu-e,HOU Li-hong,YANG Lin-hua,HAO Bin,CAO Wen-dong,WANG Xue-feng,DING Qiu-lan
DOI: https://doi.org/10.3969/j.issn.1671-2560.2007.03.003
2007-01-01
Abstract:Objective To investigate the polymorphisms in methylenetetrahydrofolate reductase(MTHFR) genes 1298A/C,1793G/A and 1317T/C in patients with venous thromboembolism(VTE) and evaluate whether these polymorphisms are associated with a VTE risk.Methods The MTHFR gene 1298A/C,1793 G/A and 1317T/C polymorphisms were investigated in 95 VTE patients(79 with deep venous thrombosis,4 with pulmonary thromboembolism and 12 with combined deep venous thrombosis and pulmonary thromboembolism) and 95 normal controls,using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry techniques.Results Distribution of the 1298A/C genotypes AA,AC and CC were 75.0%,23.9% and 1.1%,respectively,in normal individuals,with frequencies of A and C alleles being 87.0% and 13.0%.Distribution of the 1793G/A genotypes GG,GA and AA were 85.0%,8.0% and 1.0%,respectively,in the controls,with frequencies of G and A alleles being 95.7% and 4.3%.The distributions of 1298A/C or 1793 G/A polymorphisms was not found significantly different within or between groups of VTE patients and normal controls;moreover,they showed a pattern of disequilibrium.No mutations in 1317T/C were found.Conclusion The 1298A/C,1793G/A and 1317T/C polymorphisms were not associated with increased risk of VTE.
What problem does this paper attempt to address?